Shukra Pharmaceuticals Ltd — Board Meeting, 16-05-2025: Board Meeting

The company has announced a board meeting to approve the audited financial results for the quarter and financial year ended March 31, 2025, along with the auditor’s unmodified opinion. The meeting will also address any other business approved by the chairman. This is a key update signaling upcoming financial disclosures that will provide insights into the company’s performance and outlook.